カテゴリー： LP Information, 世界, 医療/バイオ

心血管薬剤溶出ステント（DES）のグローバル市場予測2023-2029

◆英語タイトル：Global Cardiovascular Drug-Eluting Stents(DES) Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23OT8442）◆商品コード：LP23OT8442
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年10月
◆ページ数：116
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「心血管薬剤溶出ステント（DES）のグローバル市場」は、過去の販売実績から2022年の世界の心血管薬剤溶出ステント（DES）の総販売量を検討し、2023年から2029年の予測される心血管薬剤溶出ステント（DES）の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の心血管薬剤溶出ステント（DES）の市場規模を掲載し、XXX百万米ドル規模の世界の心血管薬剤溶出ステント（DES）市場の詳細な分析を提供します。本インサイトレポートは、世界の心血管薬剤溶出ステント（DES）業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の心血管薬剤溶出ステント（DES）市場における各社の独自のポジションをより深く理解するために、心血管薬剤溶出ステント（DES）製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の心血管薬剤溶出ステント（DES）市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。心血管薬剤溶出ステント（DES）の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。心血管薬剤溶出ステント（DES）の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。心血管薬剤溶出ステント（DES）のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

心血管薬剤溶出ステント（DES）の世界主要メーカーとしては、MIV Therapeutics、 Orbusneich、 Promed Medical、 Relisys Medical、 Reva Medical、 Sahajanand、 Sino Medical、 Sorin、 Terumo Medical、 Abbott Vascular、 Advantec Vascular、 B.Braun Melsengen AG、 Biosensors、 Boston Scientific、 MicroPort Medicalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の心血管薬剤溶出ステント（DES）市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査では心血管薬剤溶出ステント（DES）市場をセグメンテーションし、種類別 (パッシブコーティング、アクティブコーティング)、用途別 (病院、診療所)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：パッシブコーティング、アクティブコーティング

・用途別区分：病院、診療所

・地域別区分
南北アメリカ（米国、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の心血管薬剤溶出ステント（DES）市場の10年間の市場状況・展望は？
・世界および地域別に見た心血管薬剤溶出ステント（DES）市場成長の要因は何か？
・心血管薬剤溶出ステント（DES）の市場機会はエンドマーケットの規模によってどのように変化するのか？
・心血管薬剤溶出ステント（DES）のタイプ別、用途別の内訳は？
・新型コロナウイルスとロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：心血管薬剤溶出ステント（DES）の年間販売量2018-2029、地域別現状・将来分析
・心血管薬剤溶出ステント（DES）の種類別セグメント：パッシブコーティング、アクティブコーティング
・心血管薬剤溶出ステント（DES）の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・心血管薬剤溶出ステント（DES）の用途別セグメント：病院、診療所
・心血管薬剤溶出ステント（DES）の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の心血管薬剤溶出ステント（DES）市場
・企業別のグローバル心血管薬剤溶出ステント（DES）市場データ：2018-2023年の年間販売量、市場シェア
・企業別の心血管薬剤溶出ステント（DES）の年間売上：2018-2023年の売上、市場シェア
・企業別の心血管薬剤溶出ステント（DES）販売価格
・主要企業の心血管薬剤溶出ステント（DES）生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

心血管薬剤溶出ステント（DES）の地域別レビュー
・地域別の心血管薬剤溶出ステント（DES）市場規模2018-2023：年間販売量、売上
・主要国別の心血管薬剤溶出ステント（DES）市場規模2018-2023：年間販売量、売上
・南北アメリカの心血管薬剤溶出ステント（DES）販売の成長
・アジア太平洋の心血管薬剤溶出ステント（DES）販売の成長
・ヨーロッパの心血管薬剤溶出ステント（DES）販売の成長
・中東・アフリカの心血管薬剤溶出ステント（DES）販売の成長

南北アメリカ市場
・南北アメリカの国別の心血管薬剤溶出ステント（DES）販売量、売上（2018-2023）
・南北アメリカの心血管薬剤溶出ステント（DES）の種類別販売量
・南北アメリカの心血管薬剤溶出ステント（DES）の用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の心血管薬剤溶出ステント（DES）販売量、売上（2018-2023）
・アジア太平洋の心血管薬剤溶出ステント（DES）の種類別販売量
・アジア太平洋の心血管薬剤溶出ステント（DES）の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の心血管薬剤溶出ステント（DES）販売量、売上（2018-2023）
・ヨーロッパの心血管薬剤溶出ステント（DES）の種類別販売量
・ヨーロッパの心血管薬剤溶出ステント（DES）の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の心血管薬剤溶出ステント（DES）販売量、売上（2018-2023）
・中東・アフリカの心血管薬剤溶出ステント（DES）の種類別販売量
・中東・アフリカの心血管薬剤溶出ステント（DES）の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・心血管薬剤溶出ステント（DES）の製造コスト構造分析
・心血管薬剤溶出ステント（DES）の製造プロセス分析
・心血管薬剤溶出ステント（DES）の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・心血管薬剤溶出ステント（DES）の主要なグローバル販売業者
・心血管薬剤溶出ステント（DES）の主要なグローバル顧客

地域別の心血管薬剤溶出ステント（DES）市場予測レビュー
・地域別の心血管薬剤溶出ステント（DES）市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・心血管薬剤溶出ステント（DES）の種類別市場規模予測
・心血管薬剤溶出ステント（DES）の用途別市場規模予測

主要企業分析
MIV Therapeutics、 Orbusneich、 Promed Medical、 Relisys Medical、 Reva Medical、 Sahajanand、 Sino Medical、 Sorin、 Terumo Medical、 Abbott Vascular、 Advantec Vascular、 B.Braun Melsengen AG、 Biosensors、 Boston Scientific、 MicroPort Medical
・企業情報
・心血管薬剤溶出ステント（DES）製品
・心血管薬剤溶出ステント（DES）販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cardiovascular Drug-Eluting Stents(DES) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Cardiovascular Drug-Eluting Stents(DES) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Cardiovascular Drug-Eluting Stents(DES) by Country/Region, 2018, 2022 & 2029
2.2 Cardiovascular Drug-Eluting Stents(DES) Segment by Type
2.2.1 Passive Coating
2.2.2 Active Coating
2.3 Cardiovascular Drug-Eluting Stents(DES) Sales by Type
2.3.1 Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Type (2018-2023)
2.3.2 Global Cardiovascular Drug-Eluting Stents(DES) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Cardiovascular Drug-Eluting Stents(DES) Sale Price by Type (2018-2023)
2.4 Cardiovascular Drug-Eluting Stents(DES) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Cardiovascular Drug-Eluting Stents(DES) Sales by Application
2.5.1 Global Cardiovascular Drug-Eluting Stents(DES) Sale Market Share by Application (2018-2023)
2.5.2 Global Cardiovascular Drug-Eluting Stents(DES) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Cardiovascular Drug-Eluting Stents(DES) Sale Price by Application (2018-2023)
3 Global Cardiovascular Drug-Eluting Stents(DES) by Company
3.1 Global Cardiovascular Drug-Eluting Stents(DES) Breakdown Data by Company
3.1.1 Global Cardiovascular Drug-Eluting Stents(DES) Annual Sales by Company (2018-2023)
3.1.2 Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Company (2018-2023)
3.2 Global Cardiovascular Drug-Eluting Stents(DES) Annual Revenue by Company (2018-2023)
3.2.1 Global Cardiovascular Drug-Eluting Stents(DES) Revenue by Company (2018-2023)
3.2.2 Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Company (2018-2023)
3.3 Global Cardiovascular Drug-Eluting Stents(DES) Sale Price by Company
3.4 Key Manufacturers Cardiovascular Drug-Eluting Stents(DES) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cardiovascular Drug-Eluting Stents(DES) Product Location Distribution
3.4.2 Players Cardiovascular Drug-Eluting Stents(DES) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cardiovascular Drug-Eluting Stents(DES) by Geographic Region
4.1 World Historic Cardiovascular Drug-Eluting Stents(DES) Market Size by Geographic Region (2018-2023)
4.1.1 Global Cardiovascular Drug-Eluting Stents(DES) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Cardiovascular Drug-Eluting Stents(DES) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Cardiovascular Drug-Eluting Stents(DES) Market Size by Country/Region (2018-2023)
4.2.1 Global Cardiovascular Drug-Eluting Stents(DES) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Cardiovascular Drug-Eluting Stents(DES) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Cardiovascular Drug-Eluting Stents(DES) Sales Growth
4.4 APAC Cardiovascular Drug-Eluting Stents(DES) Sales Growth
4.5 Europe Cardiovascular Drug-Eluting Stents(DES) Sales Growth
4.6 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Growth
5 Americas
5.1 Americas Cardiovascular Drug-Eluting Stents(DES) Sales by Country
5.1.1 Americas Cardiovascular Drug-Eluting Stents(DES) Sales by Country (2018-2023)
5.1.2 Americas Cardiovascular Drug-Eluting Stents(DES) Revenue by Country (2018-2023)
5.2 Americas Cardiovascular Drug-Eluting Stents(DES) Sales by Type
5.3 Americas Cardiovascular Drug-Eluting Stents(DES) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cardiovascular Drug-Eluting Stents(DES) Sales by Region
6.1.1 APAC Cardiovascular Drug-Eluting Stents(DES) Sales by Region (2018-2023)
6.1.2 APAC Cardiovascular Drug-Eluting Stents(DES) Revenue by Region (2018-2023)
6.2 APAC Cardiovascular Drug-Eluting Stents(DES) Sales by Type
6.3 APAC Cardiovascular Drug-Eluting Stents(DES) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cardiovascular Drug-Eluting Stents(DES) by Country
7.1.1 Europe Cardiovascular Drug-Eluting Stents(DES) Sales by Country (2018-2023)
7.1.2 Europe Cardiovascular Drug-Eluting Stents(DES) Revenue by Country (2018-2023)
7.2 Europe Cardiovascular Drug-Eluting Stents(DES) Sales by Type
7.3 Europe Cardiovascular Drug-Eluting Stents(DES) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) by Country
8.1.1 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Revenue by Country (2018-2023)
8.2 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales by Type
8.3 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cardiovascular Drug-Eluting Stents(DES)
10.3 Manufacturing Process Analysis of Cardiovascular Drug-Eluting Stents(DES)
10.4 Industry Chain Structure of Cardiovascular Drug-Eluting Stents(DES)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cardiovascular Drug-Eluting Stents(DES) Distributors
11.3 Cardiovascular Drug-Eluting Stents(DES) Customer
12 World Forecast Review for Cardiovascular Drug-Eluting Stents(DES) by Geographic Region
12.1 Global Cardiovascular Drug-Eluting Stents(DES) Market Size Forecast by Region
12.1.1 Global Cardiovascular Drug-Eluting Stents(DES) Forecast by Region (2024-2029)
12.1.2 Global Cardiovascular Drug-Eluting Stents(DES) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cardiovascular Drug-Eluting Stents(DES) Forecast by Type
12.7 Global Cardiovascular Drug-Eluting Stents(DES) Forecast by Application
13 Key Players Analysis
13.1 MIV Therapeutics
13.1.1 MIV Therapeutics Company Information
13.1.2 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
13.1.3 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 MIV Therapeutics Main Business Overview
13.1.5 MIV Therapeutics Latest Developments
13.2 Orbusneich
13.2.1 Orbusneich Company Information
13.2.2 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
13.2.3 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Orbusneich Main Business Overview
13.2.5 Orbusneich Latest Developments
13.3 Promed Medical
13.3.1 Promed Medical Company Information
13.3.2 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
13.3.3 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Promed Medical Main Business Overview
13.3.5 Promed Medical Latest Developments
13.4 Relisys Medical
13.4.1 Relisys Medical Company Information
13.4.2 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
13.4.3 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Relisys Medical Main Business Overview
13.4.5 Relisys Medical Latest Developments
13.5 Reva Medical
13.5.1 Reva Medical Company Information
13.5.2 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
13.5.3 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Reva Medical Main Business Overview
13.5.5 Reva Medical Latest Developments
13.6 Sahajanand
13.6.1 Sahajanand Company Information
13.6.2 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
13.6.3 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sahajanand Main Business Overview
13.6.5 Sahajanand Latest Developments
13.7 Sino Medical
13.7.1 Sino Medical Company Information
13.7.2 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
13.7.3 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sino Medical Main Business Overview
13.7.5 Sino Medical Latest Developments
13.8 Sorin
13.8.1 Sorin Company Information
13.8.2 Sorin Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
13.8.3 Sorin Cardiovascular Drug-Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sorin Main Business Overview
13.8.5 Sorin Latest Developments
13.9 Terumo Medical
13.9.1 Terumo Medical Company Information
13.9.2 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
13.9.3 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Terumo Medical Main Business Overview
13.9.5 Terumo Medical Latest Developments
13.10 Abbott Vascular
13.10.1 Abbott Vascular Company Information
13.10.2 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
13.10.3 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Abbott Vascular Main Business Overview
13.10.5 Abbott Vascular Latest Developments
13.11 Advantec Vascular
13.11.1 Advantec Vascular Company Information
13.11.2 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
13.11.3 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Advantec Vascular Main Business Overview
13.11.5 Advantec Vascular Latest Developments
13.12 B.Braun Melsengen AG
13.12.1 B.Braun Melsengen AG Company Information
13.12.2 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
13.12.3 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 B.Braun Melsengen AG Main Business Overview
13.12.5 B.Braun Melsengen AG Latest Developments
13.13 Biosensors
13.13.1 Biosensors Company Information
13.13.2 Biosensors Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
13.13.3 Biosensors Cardiovascular Drug-Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Biosensors Main Business Overview
13.13.5 Biosensors Latest Developments
13.14 Boston Scientific
13.14.1 Boston Scientific Company Information
13.14.2 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
13.14.3 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Boston Scientific Main Business Overview
13.14.5 Boston Scientific Latest Developments
13.15 MicroPort Medical
13.15.1 MicroPort Medical Company Information
13.15.2 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
13.15.3 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 MicroPort Medical Main Business Overview
13.15.5 MicroPort Medical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Cardiovascular Drug-Eluting Stents(DES) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Cardiovascular Drug-Eluting Stents(DES) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Passive Coating
Table 4. Major Players of Active Coating
Table 5. Global Cardiovascular Drug-Eluting Stents(DES) Sales by Type (2018-2023) & (K Units)
Table 6. Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Type (2018-2023)
Table 7. Global Cardiovascular Drug-Eluting Stents(DES) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Type (2018-2023)
Table 9. Global Cardiovascular Drug-Eluting Stents(DES) Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Cardiovascular Drug-Eluting Stents(DES) Sales by Application (2018-2023) & (K Units)
Table 11. Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Application (2018-2023)
Table 12. Global Cardiovascular Drug-Eluting Stents(DES) Revenue by Application (2018-2023)
Table 13. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Application (2018-2023)
Table 14. Global Cardiovascular Drug-Eluting Stents(DES) Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Cardiovascular Drug-Eluting Stents(DES) Sales by Company (2018-2023) & (K Units)
Table 16. Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Company (2018-2023)
Table 17. Global Cardiovascular Drug-Eluting Stents(DES) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Company (2018-2023)
Table 19. Global Cardiovascular Drug-Eluting Stents(DES) Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Cardiovascular Drug-Eluting Stents(DES) Producing Area Distribution and Sales Area
Table 21. Players Cardiovascular Drug-Eluting Stents(DES) Products Offered
Table 22. Cardiovascular Drug-Eluting Stents(DES) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Cardiovascular Drug-Eluting Stents(DES) Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Cardiovascular Drug-Eluting Stents(DES) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Cardiovascular Drug-Eluting Stents(DES) Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Cardiovascular Drug-Eluting Stents(DES) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Cardiovascular Drug-Eluting Stents(DES) Sales by Country (2018-2023) & (K Units)
Table 34. Americas Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Country (2018-2023)
Table 35. Americas Cardiovascular Drug-Eluting Stents(DES) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Country (2018-2023)
Table 37. Americas Cardiovascular Drug-Eluting Stents(DES) Sales by Type (2018-2023) & (K Units)
Table 38. Americas Cardiovascular Drug-Eluting Stents(DES) Sales by Application (2018-2023) & (K Units)
Table 39. APAC Cardiovascular Drug-Eluting Stents(DES) Sales by Region (2018-2023) & (K Units)
Table 40. APAC Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Region (2018-2023)
Table 41. APAC Cardiovascular Drug-Eluting Stents(DES) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Region (2018-2023)
Table 43. APAC Cardiovascular Drug-Eluting Stents(DES) Sales by Type (2018-2023) & (K Units)
Table 44. APAC Cardiovascular Drug-Eluting Stents(DES) Sales by Application (2018-2023) & (K Units)
Table 45. Europe Cardiovascular Drug-Eluting Stents(DES) Sales by Country (2018-2023) & (K Units)
Table 46. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Country (2018-2023)
Table 47. Europe Cardiovascular Drug-Eluting Stents(DES) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Country (2018-2023)
Table 49. Europe Cardiovascular Drug-Eluting Stents(DES) Sales by Type (2018-2023) & (K Units)
Table 50. Europe Cardiovascular Drug-Eluting Stents(DES) Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Cardiovascular Drug-Eluting Stents(DES)
Table 58. Key Market Challenges & Risks of Cardiovascular Drug-Eluting Stents(DES)
Table 59. Key Industry Trends of Cardiovascular Drug-Eluting Stents(DES)
Table 60. Cardiovascular Drug-Eluting Stents(DES) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Cardiovascular Drug-Eluting Stents(DES) Distributors List
Table 63. Cardiovascular Drug-Eluting Stents(DES) Customer List
Table 64. Global Cardiovascular Drug-Eluting Stents(DES) Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Cardiovascular Drug-Eluting Stents(DES) Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Cardiovascular Drug-Eluting Stents(DES) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Cardiovascular Drug-Eluting Stents(DES) Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Cardiovascular Drug-Eluting Stents(DES) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Cardiovascular Drug-Eluting Stents(DES) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Cardiovascular Drug-Eluting Stents(DES) Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Cardiovascular Drug-Eluting Stents(DES) Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. MIV Therapeutics Basic Information, Cardiovascular Drug-Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 79. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
Table 80. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. MIV Therapeutics Main Business
Table 82. MIV Therapeutics Latest Developments
Table 83. Orbusneich Basic Information, Cardiovascular Drug-Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 84. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
Table 85. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Orbusneich Main Business
Table 87. Orbusneich Latest Developments
Table 88. Promed Medical Basic Information, Cardiovascular Drug-Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 89. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
Table 90. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Promed Medical Main Business
Table 92. Promed Medical Latest Developments
Table 93. Relisys Medical Basic Information, Cardiovascular Drug-Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 94. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
Table 95. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Relisys Medical Main Business
Table 97. Relisys Medical Latest Developments
Table 98. Reva Medical Basic Information, Cardiovascular Drug-Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 99. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
Table 100. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Reva Medical Main Business
Table 102. Reva Medical Latest Developments
Table 103. Sahajanand Basic Information, Cardiovascular Drug-Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 104. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
Table 105. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Sahajanand Main Business
Table 107. Sahajanand Latest Developments
Table 108. Sino Medical Basic Information, Cardiovascular Drug-Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 109. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
Table 110. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Sino Medical Main Business
Table 112. Sino Medical Latest Developments
Table 113. Sorin Basic Information, Cardiovascular Drug-Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 114. Sorin Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
Table 115. Sorin Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Sorin Main Business
Table 117. Sorin Latest Developments
Table 118. Terumo Medical Basic Information, Cardiovascular Drug-Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 119. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
Table 120. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Terumo Medical Main Business
Table 122. Terumo Medical Latest Developments
Table 123. Abbott Vascular Basic Information, Cardiovascular Drug-Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 124. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
Table 125. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Abbott Vascular Main Business
Table 127. Abbott Vascular Latest Developments
Table 128. Advantec Vascular Basic Information, Cardiovascular Drug-Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 129. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
Table 130. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Advantec Vascular Main Business
Table 132. Advantec Vascular Latest Developments
Table 133. B.Braun Melsengen AG Basic Information, Cardiovascular Drug-Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 134. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
Table 135. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. B.Braun Melsengen AG Main Business
Table 137. B.Braun Melsengen AG Latest Developments
Table 138. Biosensors Basic Information, Cardiovascular Drug-Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 139. Biosensors Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
Table 140. Biosensors Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Biosensors Main Business
Table 142. Biosensors Latest Developments
Table 143. Boston Scientific Basic Information, Cardiovascular Drug-Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 144. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
Table 145. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Boston Scientific Main Business
Table 147. Boston Scientific Latest Developments
Table 148. MicroPort Medical Basic Information, Cardiovascular Drug-Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 149. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Product Portfolios and Specifications
Table 150. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. MicroPort Medical Main Business
Table 152. MicroPort Medical Latest Developments
List of Figures
Figure 1. Picture of Cardiovascular Drug-Eluting Stents(DES)
Figure 2. Cardiovascular Drug-Eluting Stents(DES) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cardiovascular Drug-Eluting Stents(DES) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Cardiovascular Drug-Eluting Stents(DES) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Passive Coating
Figure 10. Product Picture of Active Coating
Figure 11. Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Type in 2022
Figure 12. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Type (2018-2023)
Figure 13. Cardiovascular Drug-Eluting Stents(DES) Consumed in Hospital
Figure 14. Global Cardiovascular Drug-Eluting Stents(DES) Market: Hospital (2018-2023) & (K Units)
Figure 15. Cardiovascular Drug-Eluting Stents(DES) Consumed in Clinic
Figure 16. Global Cardiovascular Drug-Eluting Stents(DES) Market: Clinic (2018-2023) & (K Units)
Figure 17. Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Application (2022)
Figure 18. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Application in 2022
Figure 19. Cardiovascular Drug-Eluting Stents(DES) Sales Market by Company in 2022 (K Units)
Figure 20. Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Company in 2022
Figure 21. Cardiovascular Drug-Eluting Stents(DES) Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Company in 2022
Figure 23. Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Cardiovascular Drug-Eluting Stents(DES) Sales 2018-2023 (K Units)
Figure 26. Americas Cardiovascular Drug-Eluting Stents(DES) Revenue 2018-2023 ($ Millions)
Figure 27. APAC Cardiovascular Drug-Eluting Stents(DES) Sales 2018-2023 (K Units)
Figure 28. APAC Cardiovascular Drug-Eluting Stents(DES) Revenue 2018-2023 ($ Millions)
Figure 29. Europe Cardiovascular Drug-Eluting Stents(DES) Sales 2018-2023 (K Units)
Figure 30. Europe Cardiovascular Drug-Eluting Stents(DES) Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Revenue 2018-2023 ($ Millions)
Figure 33. Americas Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Country in 2022
Figure 34. Americas Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Country in 2022
Figure 35. Americas Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Type (2018-2023)
Figure 36. Americas Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Application (2018-2023)
Figure 37. United States Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Region in 2022
Figure 42. APAC Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Regions in 2022
Figure 43. APAC Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Type (2018-2023)
Figure 44. APAC Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Application (2018-2023)
Figure 45. China Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Country in 2022
Figure 53. Europe Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Country in 2022
Figure 54. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Type (2018-2023)
Figure 55. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Application (2018-2023)
Figure 56. Germany Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Market Share by Application (2018-2023)
Figure 65. Egypt Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Cardiovascular Drug-Eluting Stents(DES) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Cardiovascular Drug-Eluting Stents(DES) in 2022
Figure 71. Manufacturing Process Analysis of Cardiovascular Drug-Eluting Stents(DES)
Figure 72. Industry Chain Structure of Cardiovascular Drug-Eluting Stents(DES)
Figure 73. Channels of Distribution
Figure 74. Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Forecast by Region (2024-2029)
Figure 75. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 心血管薬剤溶出ステント（DES）のグローバル市場予測2023-2029(Global Cardiovascular Drug-Eluting Stents(DES) Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の心血管薬剤溶出ステント（DES）市場2023年：企業・地域・タイプ・用途別分析
  • 薬剤溶出ステントの世界市場2023年～2030年：コーティング別、用途別、エンドユーザー別、地域別
  • 薬剤溶出性ステントのグローバル市場予測2023-2029

    • ◆H&Iグローバルリサーチのお客様（例）◆